CEP55 and bladder transitional cell carcinoma: CEP55 was elevated in high-grade (Grades III and IV) malignancies in BLCA, KIRC, HNSC, LIHC, LGG, OV, and UCEC, but showed reduced expression in high-grade CESC and STAD tumors (Figure 2E; Supplementary Figure S2B).